At the time of writing, Celularity Inc [CELU] stock is trading at $2.65, up 33.17%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CELU shares have gain 13.25% over the last week, with a monthly amount glided 15.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Celularity Inc [NASDAQ: CELU] stock has seen the most recent analyst activity on January 30, 2023, when Morgan Stanley downgraded its rating to a Underweight and also revised its price target to $1 from $5. Previously, Oppenheimer downgraded its rating to Perform on December 22, 2022. On June 22, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $15 on the stock. Truist downgraded its rating to a Hold but stick to its price target of $10 on April 06, 2022. Oppenheimer initiated its recommendation with a Outperform and recommended $9 as its price target on January 28, 2022. Morgan Stanley started tracking with a Equal-Weight rating for this stock on November 24, 2021, and assigned it a price target of $9.
For the past year, the stock price of Celularity Inc fluctuated between $1.30 and $7.97. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Celularity Inc [NASDAQ: CELU] shares were valued at $2.65 at the most recent close of the market. An investor can expect a potential return of 13.21% based on the average CELU price forecast.
Analyzing the CELU fundamentals
According to Celularity Inc [NASDAQ:CELU], the company’s sales were 48.20M for trailing twelve months, which represents an 145.54% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.33%, Pretax Profit Margin comes in at -0.73%, and Net Profit Margin reading is -0.73%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -1.2 and Total Capital is -0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 4.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.1200 points at the first support level, and at 1.5800 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.0400, and for the 2nd resistance point, it is at 3.4200.
Ratios To Look Out For
It is important to note that Celularity Inc [NASDAQ:CELU] has a current ratio of 0.19. As well, the Quick Ratio is 0.14, while the Cash Ratio is 0.0. Considering the valuation of this stock, the price to sales ratio is 1.31, the price to book ratio is 3.37.
